WO2001012659A3 - Human dna sequences - Google Patents

Human dna sequences Download PDF

Info

Publication number
WO2001012659A3
WO2001012659A3 PCT/IB2000/001496 IB0001496W WO0112659A3 WO 2001012659 A3 WO2001012659 A3 WO 2001012659A3 IB 0001496 W IB0001496 W IB 0001496W WO 0112659 A3 WO0112659 A3 WO 0112659A3
Authority
WO
WIPO (PCT)
Prior art keywords
clones
sequence
dna sequences
human dna
disclosed sequence
Prior art date
Application number
PCT/IB2000/001496
Other languages
French (fr)
Other versions
WO2001012659A2 (en
Inventor
Stefan Wiemann
Annemarie Poustka
Ruth Wellenreuther
Original Assignee
Fraunhofer Ges Forschung
Stefan Wiemann
Annemarie Poustka
Ruth Wellenreuther
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung, Stefan Wiemann, Annemarie Poustka, Ruth Wellenreuther filed Critical Fraunhofer Ges Forschung
Priority to AU76803/00A priority Critical patent/AU7680300A/en
Priority to EP00966368A priority patent/EP1248798A2/en
Publication of WO2001012659A2 publication Critical patent/WO2001012659A2/en
Publication of WO2001012659A3 publication Critical patent/WO2001012659A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Novel human cDNA sequence of a clones, the encoded protein sequence of a clones, antibodies and variants thereof, are provided. The disclosed sequence of a clones find application in a number of ways, including use in profiling assays. In this regard, various assemblages of nucleic acids or proteins are provided that are useful in providing large arrays of human material for implementing large-scale screening strategies. The disclosed sequence of a clones may also be used in formulating medicaments, treating various disorders and in certain diagnostic applications.
PCT/IB2000/001496 1999-08-18 2000-08-18 Human dna sequences WO2001012659A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU76803/00A AU7680300A (en) 1999-08-18 2000-08-18 Human dna sequences
EP00966368A EP1248798A2 (en) 1999-08-18 2000-08-18 Human dna sequences

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15650399P 1999-08-18 1999-08-18
US14949999P 1999-08-18 1999-08-18
US60/149,499 1999-08-18
US60/156,503 1999-09-28

Publications (2)

Publication Number Publication Date
WO2001012659A2 WO2001012659A2 (en) 2001-02-22
WO2001012659A3 true WO2001012659A3 (en) 2002-06-20

Family

ID=26846790

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2000/001496 WO2001012659A2 (en) 1999-08-18 2000-08-18 Human dna sequences

Country Status (3)

Country Link
EP (1) EP1248798A2 (en)
AU (1) AU7680300A (en)
WO (1) WO2001012659A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9475873B2 (en) 2009-05-05 2016-10-25 Novimmune Sa Nucleic acids encoding anti-IL-17F antibodies and methods of use thereof

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
US20040058355A1 (en) 1998-09-30 2004-03-25 Millennium Pharmaceuticals, Inc. Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
US6514719B1 (en) 1999-05-28 2003-02-04 Immunex Corporation Methods for identifying compounds that alter kinase activity
US7001752B1 (en) 1999-05-28 2006-02-21 Immunex Corporation Murine and human kinases
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
EP1633872A2 (en) * 1999-09-24 2006-03-15 Lexicon Genetics Incorporated Novel human protease inhibitor-like proteins and polynucleotides encoding the same
WO2001025250A1 (en) * 1999-10-06 2001-04-12 The Regents Of The University Of California Differentially expressed genes associated with her-2/neu overexpression
US6770477B1 (en) 1999-10-06 2004-08-03 The Regents Of The University Of California Differentially expressed genes associated with HER-2/neu overexpression
EP2258848B1 (en) * 1999-12-23 2014-03-05 Genentech, Inc. Il-17 homologous polypeptide and therapeutic uses thereof
WO2001059114A2 (en) * 2000-02-09 2001-08-16 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services Tumor suppressor gene, p47ing3
AU2001241880A1 (en) 2000-02-29 2001-09-12 Millennium Pharmaceuticals, Inc. 2504, 15977, and 14760, novel protein kinase family members and uses therefor
JP2003526370A (en) * 2000-03-16 2003-09-09 アムジェン インコーポレーテッド IL-17 receptor-like molecules and uses thereof
US20010049106A1 (en) * 2000-04-27 2001-12-06 Leonard Buckbinder ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
WO2001083705A1 (en) * 2000-04-27 2001-11-08 Kyowa Hakko Kogyo Co., Ltd. Myocardial cell proliferation-associated genes
WO2001085942A2 (en) * 2000-05-05 2001-11-15 Incyte Genomics, Inc. Cytoskeleton-associated proteins
EP1290186A2 (en) 2000-05-31 2003-03-12 Bayer Aktiengesellschaft Regulation of a human transketolase-like enzyme
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1254912A1 (en) * 2001-04-30 2002-11-06 Boehringer Ingelheim International GmbH Cyk-4 polypeptides, DNA molecules encoding them and their use in screening methods
JP2003535606A (en) * 2000-06-19 2003-12-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cyk-4 polypeptides, DNAs encoding them and their use in screening methods
US20030105288A1 (en) * 2000-07-25 2003-06-05 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6534309B1 (en) * 2000-08-03 2003-03-18 Cytokinetics, Inc. Motor proteins and methods for their use
JP2004537255A (en) * 2000-09-20 2004-12-16 ピーイー コーポレイション （エヌワイ） Isolated human transporter protein, nucleic acid molecule encoding human transporter protein, and uses thereof
WO2002024921A2 (en) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. 3700, a novel human protein kinase and uses therefor
TW499433B (en) 2000-12-27 2002-08-21 Ind Tech Res Inst Novel human Α1-chain collagen
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
AU2002328200B2 (en) * 2001-09-27 2008-01-03 Bionomics Limited DNA sequences for human angiogenesis genes
WO2003027285A1 (en) * 2001-09-27 2003-04-03 Bionomics Limited Dna sequences for human angiogenesis genes
EP1458754B1 (en) * 2001-12-18 2009-12-09 Endocube SAS Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
JP2004097199A (en) * 2002-07-15 2004-04-02 Keio Gijuku Method for screening tumor antigen
US20060257387A1 (en) * 2002-08-07 2006-11-16 National Institute Of Advanced Industrial Science And Technology Sugar chain synthase gene
WO2004018669A1 (en) * 2002-08-21 2004-03-04 Proteinexpress Co., Ltd. Salt-inducible kinases 2 and use thereof
JP2006515165A (en) * 2002-09-16 2006-05-25 ジェネンテック・インコーポレーテッド Novel compositions and methods for the treatment of immune related diseases
DE50207801D1 (en) 2002-09-18 2006-09-21 Sirs Lab Gmbh Method for detecting prokaryotic DNA
US7718787B2 (en) * 2002-10-18 2010-05-18 Lg Life Sciences Limited Gene families associated with cancers
US7423018B2 (en) * 2002-12-13 2008-09-09 University Of Massachusetts Kinesin-like proteins and methods of use
US7632640B2 (en) * 2003-12-08 2009-12-15 The Clinic For Special Children Association of TSPYL polymorphisms with SIDDT syndrome
ES2384571T3 (en) * 2004-03-05 2012-07-09 Sirs-Lab Gmbh Procedure for enrichment and / or separation of prokaryotic DNA by a protein that specifically binds to DNA containing unmethylated CpG motifs
EP1732382A4 (en) * 2004-03-17 2009-01-07 Univ Virginia Sfec, a sperm flagellar energy carrier protein
CA2577423C (en) 2004-08-16 2012-11-06 Quark Biotech, Inc. Therapeutic uses of inhibitors of rtp801
WO2006029176A2 (en) * 2004-09-08 2006-03-16 Ludwig Institute For Cancer Research Cancer-testis antigens
US7332591B2 (en) * 2004-12-21 2008-02-19 The University Of Iowa Research Foundation Bardet-Biedl susceptibility gene and uses thereof
NL2000439C2 (en) 2006-01-20 2009-03-16 Quark Biotech Therapeutic applications of inhibitors of RTP801.
US7825099B2 (en) 2006-01-20 2010-11-02 Quark Pharmaceuticals, Inc. Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
US7723052B2 (en) 2006-05-11 2010-05-25 Quark Pharmaceuticals, Inc. Screening systems utilizing RTP801
EP2026843A4 (en) 2006-06-09 2011-06-22 Quark Pharmaceuticals Inc Therapeutic uses of inhibitors of rtp801l
US7872119B2 (en) 2007-02-26 2011-01-18 Quark Pharmaceuticals, Inc. Inhibitors of RTP801 and their use in disease treatment
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
NZ623706A (en) 2008-05-05 2015-12-24 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
US20120110684A1 (en) * 2009-03-24 2012-05-03 INSERM (Institut National de la Sante st de la Recherche Medicale)- Method for Diagnosing or Predicting a Non Syndromic Autosomal Recessive Optic Atrophy, or a Risk of a Non Syndromic Autosomal Recessive Optic Atrophy
CN103421742B (en) * 2013-05-31 2015-01-28 华中农业大学 Recombinant monoclonal antibodies H2 resisting fumonisins B1
CN103421743B (en) * 2013-05-31 2015-01-28 华中农业大学 Recombinant monoclonal antibodies H7 resisting fumonisins B1
DE102020210725A1 (en) * 2019-10-31 2021-05-06 Gelita Ag Nutritionally optimized collagen peptide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040486A2 (en) * 1997-03-14 1998-09-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2000009552A1 (en) * 1998-08-14 2000-02-24 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040486A2 (en) * 1997-03-14 1998-09-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2000009552A1 (en) * 1998-08-14 2000-02-24 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Atlas(tm) human cDNA expression array I", CLONTECHNIQUES, April 1977 (1977-04-01), US, pages 4 - 7, XP002914393 *
HILLIER L ET AL.: "Human cDNA clone IMAGE: 754167", EMBL SEQUENCE DATABASE, 23 June 1997 (1997-06-23), HEIDELBERG DE, XP002163419 *
HILLIER L ET AL.: "Human cDNA clone IMAGE:263887", EMBL SEQUENCE DATABASE, 5 January 1996 (1996-01-05), HEIDELBERG DE, XP002163421 *
HILLIER L ET AL: "Human cDNA clone IMAGE:754267", EMBL SEQUENCE DATABASE, 23 July 1997 (1997-07-23), HEIDELBERG DE, XP002163418 *
REICHERT J ET AL: "HUMAN AND RODENT EXPRESSION PATTERN OF A FUSION GENE ISOLATED FROM AN MCF7 CDNA LIBRARY", INTERNATIONAL JOURNAL OF ONCOLOGY, vol. 9, no. 1, 1996, pages 29 - 32, XP000906725 *
STRAUSBERG R ET AL.: "Human cDNA sequence IMAGE:2138166", EMBL SEQUENCE DATABASE, 24 March 1999 (1999-03-24), HEIDELBERG DE, XP002163420 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9475873B2 (en) 2009-05-05 2016-10-25 Novimmune Sa Nucleic acids encoding anti-IL-17F antibodies and methods of use thereof

Also Published As

Publication number Publication date
WO2001012659A2 (en) 2001-02-22
EP1248798A2 (en) 2002-10-16
AU7680300A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
WO2001012659A3 (en) Human dna sequences
CA2295999A1 (en) Nik proteins, nucleic acids and methods
CA2294516A1 (en) Ikk-.beta. proteins, nucleic acids and methods
WO2000054046A3 (en) Universal protein array system
WO1996001614A3 (en) Rna component of telomerase
WO1995025171A3 (en) Dna sequences for matrix metalloproteases, their production and use
WO2002012338A3 (en) Screening method
WO1998006841A3 (en) Two human nsp-like proteins
ATE245190T1 (en) ROBO: A FAMILY OF POLYPEPTIDES AND NUCLEIC ACIDS EFFECTIVE IN NERVE CELL CONDUCTION
CA2336261A1 (en) Cyclin e2 genes and proteins
WO1995011919A3 (en) Recombinant pilc proteins, process for producing them and their use
WO2003016551A3 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
CA2495529A1 (en) Noonan syndrome gene
DE69736801D1 (en) CLEANED PROTEINS, RECOMBINANT DNA SEQUENCES AND PROCESSES FOR THE PRODUCTION OF CASE-FREE DRINKS
WO1998025956A3 (en) Human GTP-binding proteins
BR0000698A (en) Beta 15, 15'-dioxigenases, beta-carotene
WO2001042287A3 (en) Putative human g-protein coupled receptors
WO2001074903A3 (en) Cd20/ige-receptor like molecules and uses thereof
WO2001032693A3 (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
EP0780472A3 (en) Stress proteins
WO2000043510A3 (en) Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use
WO2001040461A3 (en) Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and c
WO1998018942A3 (en) Novel human rab proteins
DE69631624D1 (en) ANTIBODIES AGAINST HUMAN RESTRICTIN
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000966368

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000966368

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000966368

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP